The Confederation may undertake to cover any loss or damage for which the manufacturer of a therapeutic product under Article 44 may be held liable as the consequence of the product being used as recommended or ordered by the Confederation in a special or extraordinary situation.
The extent and the modalities of the cover shall be set out in an agreement between the Confederation and the manufacturer.
0 commentaries
No commentaries are available for this article yet.